News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Vivo Capital IX, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Bought 3,157,894 shares
@ $1.9, valued at
$6M
Bought 3,157,894 warrants
@ $2.47, valued at
$7.8M
|
|
| 07/05/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 0% stake in Sierra Oncology, Inc. |
| 07/01/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 161,712 shares
@ $55, valued at
$8.9M
Disposed/sold 2,735,853 shares
@ $55, valued at
$150.5M
Disposed/sold 431,947 shares
@ $55, valued at
$23.8M
Disposed/sold 324,740 options to buy
@ $13.2, valued at
$4.3M
Disposed/sold 1,455,384 options to buy
@ $13.2, valued at
$19.2M
Disposed/sold 75,749 options to buy
@ $13.2, valued at
$999.9k
|
|
| 05/04/2022 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 41,800 shares
@ $15.19, valued at
$634.9k
Sold 451,418 shares
@ $13.25, valued at
$6M
Sold 19,738 shares
@ $12.67, valued at
$250.1k
|
|
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 1.8% stake in Larimar Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 7.8% stake in Mereo BioPharma Group plc |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 4.5% stake in IVERIC bio, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 1.4% stake in ESSA Pharma Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14.7% stake in Sierra Oncology, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14.4% stake in Tarsus Pharmaceuticals, Inc. |
| 01/31/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 800,000 shares
@ $27, valued at
$21.6M
|
|
| 01/28/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Exercised (in-or-at-the-money) 75,749 options to buy
@ $13.2, valued at
$999.9k
Exercised (in-or-at-the-money) 1,455,384 options to buy
@ $13.2, valued at
$19.2M
Exercised (in-or-at-the-money) 324,740 options to buy
@ $13.2, valued at
$4.3M
|
|
| 11/12/2021 |
SC 13G
| Vivo Capital IX, LLC reports a 10.5% stake in IO Biotech, Inc. |
| 11/12/2021 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Converted 2,365,545 shares
@ $0
Bought 650,000 shares
@ $14, valued at
$9.1M
Converted 188,168 preferred shares
@ $0 |
|
| 11/05/2021 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14.8% stake in Sierra Oncology, Inc. |
| 11/04/2021 |
3
| Vivo Capital IX, LLC (10% Owner) has filed a Form 3 on IO Biotech, Inc. |
| 07/23/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 03/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/06/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 4.4% stake in ESSA Pharma Inc. |
| 10/28/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 16.2% stake in Tarsus Pharmaceuticals, Inc. |
| 10/20/2020 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Converted 2,780,754 shares
@ $0
Converted 214,281 shares
@ $0
Bought 250,000 shares
@ $16, valued at
$4M
Converted 2,780,754 preferred shares
@ $0
Converted 214,281 preferred shares
@ $0 |
|
| 10/15/2020 |
3
| Vivo Capital IX, LLC (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
| 07/29/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 11.1% stake in ALX Oncology Holdings Inc. |
|
|
|